BRIEF-Curanex Pharmaceuticals - Expects IPO Price Will Be Between $4.00 And $6.00 Per Share-February 2024-www.financetom.com

BRIEF-Curanex Pharmaceuticals - Expects IPO Price Will Be Between $4.00 And $6.00 Per Share

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Curanex Pharmaceuticals - Expects IPO Price Will Be Between $4.00 And $6.00 Per Share

Oct 17, 2024 2:01 PM

Oct 16 (Reuters) -

* CURANEX PHARMACEUTICALS INC - EXPECTS IPO PRICE WILL BE

BETWEEN

US$4.00 AND US$6.00 PER SHARE

* CURANEX PHARMACEUTICALS INC SAYS DOMINARI SECURITIES AND

REVERE

SECURITIES ARE UNDERWRITERS TO IPO- SEC FILING

* CURANEX PHARMACEUTICALS INC FILES FOR IPO OF 3.75 MILLION

OF COMMON STOCK - SEC FILING

* CURANEX PHARMACEUTICALS INC - REGISTERING IN OFFERING 2

MILLION

SHARES OF COMMON STOCK ON FIRM COMMITMENT UNDERWRITTEN BASIS

* CURANEX PHARMACEUTICALS INC - ALSO REGISTERING UP TO 1.75

MILLION SHARES OF COMMON STOCK FOR RESALE BY SELLING STOCKHOLDER

* CURANEX PHARMACEUTICALS: INTENDS TO APPLY FOR LISTING ON

NASDAQ

CAPITAL MARKET UNDER THE SYMBOL "CURX"

Source text for Eikon:

Previous page： Update: Osisko Gold Royalties Gains 2.2% as It Books Record Preliminary Q4 Revenue Next page： Large-Cap Banks Poised for 'Robust' Q4 Capital Markets Revenue, Morgan Stanley Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Osisko Gold Royalties Gains 2.2% as It Books Record Preliminary Q4 Revenue

Jan 7, 2025

11:54 AM EST, 01/07/2025 (MT Newswires) -- Osisko Gold Royalties ( OR ) reported Tuesday record preliminary fourth-quarter revenue. Osisko's record revenue from royalties and streams of $79.3 million and cost of sales of $3.1 million, resulting in a record quarterly cash margin of $76.3 million. The company said it earned 20,005 attributable gold equivalent ounces (GEO) for a total...

Large-Cap Banks Poised for 'Robust' Q4 Capital Markets Revenue, Morgan Stanley Says

Jan 7, 2025

11:56 AM EST, 01/07/2025 (MT Newswires) -- Major US banks are expected to report robust Q4 capital markets revenue, especially in trading and equity capital markets, with Citigroup ( C ) seen as the top pick, Morgan Stanley said Tuesday. The firm said that JPMorgan Chase ( JPM ) , State Street (STT) and U.S. Bancorp ( USB ) are...

Catheter Precision Appoints Philip Anderson as CFO

Jan 7, 2025

12:00 PM EST, 01/07/2025 (MT Newswires) -- Catheter Precision ( VTAK ) said Tuesday it has appointed Philip Anderson as chief financial officer. Anderson succeeds interim CFO Margrit Thomassen, who will continue in the role of controller, the company said. Catheter Precision's ( VTAK ) shares were down 6.3% in recent trading. Price: 0.53, Change: -0.04, Percent Change: -6.25 ...

Tesla Long-Term Growth Potential Largely Priced In, Execution Risk Now High, BofA Says

Jan 7, 2025

11:54 AM EST, 01/07/2025 (MT Newswires) -- Tesla's (TSLA) latest valuation already reflects long-term growth potential, including its robotaxis, BofA Securities said Tuesday in a note. Tesla is trading at a level that captures much of our base case long-term potential from core autos, robotaxi, Optimus, and energy generation & storage, BofA said, noting that robotaxis account for about 50%...